PDCD1 and non-small cell lung carcinoma: A case report study showed that administration of Nivolumab (anti-PD1) in one HIV infected patient with advanced non-small cell lung cancer (NSCLC) led to a mild and transient increase in cell-associated HIV DNA (219).